Abbr. Expansion Instances Papers News
HCC hepatocellular carcinoma
BACKGROUND AIMS Understanding the mechanisms of hepatocellular carcinoma (HCC) progression and metastasis is crucial to improve early diagnosis and treatment.
40 34 6
TCGA The Cancer Genome Atlas
The Cancer Genome Atlas (TCGA), real-time quantitative RT-PCR (qRT-PCR), immunoblot, and immunohistochemical analyses were applied to evaluate the TNNT1 expression of human HCC.
15 15 0
CRP C-reactive protein
Peripheral blood was drawn before and after surgery to detect the inflammatory factors C-reactive protein (CRP), calcitoninogen (PCT), tumor necrosis factor-α (TNF-α), gastric function gastrin 17 (G-17), and pepsinogen (PG) I and II.
15 15 0
LOS length of stay
The operative time, intraoperative bleeding, postoperative ventilation time, length of stay (LOS) and perioperative complication rates were compared between the two groups.
12 12 0
GC gastric cancer
OBJECTIVE To investigate the effect of laparoscopic radical gastrectomy on the inflammation and recovery of gastrointestinal function in elderly patients with advanced gastric cancer (GC).
12 12 0
TNF-α tumor necrosis factor-α
Peripheral blood was drawn before and after surgery to detect the inflammatory factors C-reactive protein (CRP), calcitoninogen (PCT), tumor necrosis factor-α (TNF-α), gastric function gastrin 17 (G-17), and pepsinogen (PG) I and II.
11 11 0
DFS disease-free survival
Cox multivariate regression suggested DOI and delay in starting radiation to be significant prognostic factors for disease-free survival (DFS).
10 10 0
SEER Surveillance, Epidemiology, and End Results
METHODS Patients diagnosed with nonmetastatic HNRMS between 2004 and 2015 from the Surveillance, Epidemiology, and End Results (SEER) database were enrolled in our study.
9 9 0
DCA decision curve analysis
The receiver operating characteristic curve and decision curve analysis (DCA) demonstrated the novel M-Index based on tumor morphology and rim location outperformed R.E.N.A.L, PADUA, DAP, and C-Index in the prediction of pathological upstaging (area under curve 0.756 vs. 0.728 vs. 0.641 vs. 0.661 vs. 0.743).
9 9 0
ESCC esophageal squamous cell carcinoma
METHODS Patients with esophageal squamous cell carcinoma (ESCC) who underwent subtotal esophagectomy at 85 authorized institutes were retrospectively reviewed from 2010 to 2015.
7 7 0